Expression of CD44, PCNA and E-cadherin in Pterygium Tissue
Launched by BALIKESIR UNIVERSITY · Sep 15, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a condition called pterygium, which is a growth of tissue on the eye that can cause vision problems. Researchers want to learn more about certain proteins, like CD44, PCNA, and E-cadherin, that may play a role in how pterygium develops and comes back after treatment. Understanding these proteins could help improve how pterygium is treated in the future.
If you have pterygium and are interested in participating, you may be eligible for this study. However, individuals with a similar condition called pseudopterygium cannot take part. Since the trial is not yet recruiting participants, you will need to wait until it starts to find out more about what being a participant involves. This trial aims to gather information that could help better manage this eye condition and improve patient care.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: patient with pterygium -
- • Exclusion Criteria: patient with pseudopterygium
- • -
About Balikesir University
Balikesir University is a prominent educational institution in Turkey, recognized for its commitment to advancing research and innovation in the medical field. As a clinical trial sponsor, the university leverages its extensive academic resources and expertise to facilitate rigorous and ethical research studies aimed at improving healthcare outcomes. Balikesir University collaborates with a diverse range of stakeholders, including healthcare professionals and industry partners, to drive clinical advancements and contribute to the global body of medical knowledge. Through its dedication to scientific excellence and patient safety, Balikesir University plays a vital role in the development of new therapies and treatment modalities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Balıkesir, , Turkey
Patients applied
Trial Officials
HÜMEYRA YILDIRIM
Principal Investigator
Balıkesir Medical Faculty
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported